Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: GeneDx Hldgs Q3 Adj. EPS $0.49 Beats $0.42 Estimate, Sales $116.743M Beat $104.670M Estimate

Author: Benzinga Newsdesk | October 28, 2025 05:44am
GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.42 by 15.84 percent. This is a 600 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $116.743 million which beat the analyst consensus estimate of $104.670 million by 11.53 percent. This is a 51.86 percent increase over sales of $76.874 million the same period last year.

Posted In: WGS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist